Sign inGet started

Lucidi Bruno

Insider CIK 1829622 · AVIR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AVIR Atea Pharmaceuticals, Inc. A Award deriv2026-06-182026-06-2326,700— $026,700SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2026-06-182026-06-2329,600— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2026-06-182026-06-2337,700— $037,700SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise2026-06-182026-06-2329,600— $0142,350SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2025-06-202025-06-2429,600— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2025-06-202025-06-2429,600— $029,600SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2025-06-202025-06-2441,200— $041,200SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise2025-06-202025-06-2429,600— $0112,750SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2024-06-212024-06-2129,600— $029,600SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2024-06-212024-06-2141,200— $041,200SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise deriv2024-06-162024-06-1833,150— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. M Exercise2024-06-162024-06-1833,150— $083,150SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2023-06-162023-06-2146,750— $046,750SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2023-06-162023-06-2133,150— $033,150SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2022-06-172022-06-2161,264— $061,264SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2021-06-182021-06-2134,025— $034,025SEC↗
AVIR Atea Pharmaceuticals, Inc. A Award deriv2020-10-292020-10-3080,000— $080,000SEC↗